1
40
2
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
8–9
Issue
1
Volume
37
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Fungal Endophthalmitis: Another Risk Associated With Intravenous Drug Use.
Publisher
An entity responsible for making the resource available
Infectious Disease Alert
Date
A point or period of time associated with an event in the lifecycle of the resource
2017
2017-10
Subject
The topic of the resource
Substance Abuse; Treatment Outcomes; Fungemia; Intravenous Drug Users; Visual Acuity; Antifungal Agents – Administration and Dosage; Communicable Diseases – Risk Factors; Endophthalmitis – Risk Factors; Endophthalmitis – Surgery; Eye Infections; Fungal – Risk Factors; Intravenous – Complications; Vision Disorders – Risk Factors
Creator
An entity primarily responsible for making the resource
Watkins Richard R
Description
An account of the resource
A retrospective cohort study found that endogenous fungal endophthalmitis is associated with intravenous drug use and frequently results in poor visual outcomes despite appropriate surgical and antifungal therapy.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2017
Antifungal Agents – Administration and Dosage
Communicable Diseases – Risk Factors
Department of Internal Medicine
Endophthalmitis – Risk Factors
Endophthalmitis – Surgery
Eye Infections
Fungal – Risk Factors
Fungemia
Infectious Disease Alert
Intravenous – Complications
Intravenous Drug Users
NEOMED College of Medicine
Substance Abuse
Treatment Outcomes
Vision Disorders – Risk Factors
Visual Acuity
Watkins Richard R
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.2165/00002512-200421020-00003" target="_blank" rel="noreferrer noopener">http://doi.org/10.2165/00002512-200421020-00003</a>
Pages
101–112
Issue
2
Volume
21
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Common fungal infections of the feet in patients with diabetes mellitus.
Publisher
An entity responsible for making the resource available
Drugs & Aging
Date
A point or period of time associated with an event in the lifecycle of the resource
2004
2004-01-15
Subject
The topic of the resource
Drug Interactions; Clinical Trials; Administration; Topical; Oral; Foot Diseases – Diagnosis; Antifungal Agents – Therapeutic Use; Antifungal Agents – Administration and Dosage; Diabetes Mellitus – Complications; Antifungal Agents – Adverse Effects; Antifungal Agents – Pharmacokinetics; Foot Diseases – Classification; Foot Diseases – Drug Therapy; Foot Diseases – Epidemiology; Foot Diseases – Etiology; Foot Diseases – Microbiology; Foot Diseases – Symptoms; Mycoses – Classification; Mycoses – Diagnosis; Mycoses – Drug Therapy; Mycoses – Epidemiology; Mycoses – Etiology; Mycoses – Microbiology; Mycoses – Symptoms
Creator
An entity primarily responsible for making the resource
Tan J S; Joseph WS
Description
An account of the resource
Superficial fungal infections of the foot (tinea pedis and onychomycosis) are common among elderly patients. Although most authorities believe that patients with diabetes mellitus have an increased predisposition to dermatophytic infections, some controversies still remain. Because these infections disrupt the skin integrity and provide an avenue for bacterial superinfection, elderly diabetic patients with dermatophytic infection should be promptly treated with an antifungal agent. For most dermatophytic infections of the foot, topical agents are usually effective and less expensive than oral agents. Laboratory diagnosis of fungal infection prior to institution of therapy is recommended. Proper technique for obtaining the specimen is important to ensure a higher chance of isolating the infecting fungus. Commonly used anti-dermatophytic agents that are also active against the yeasts include the imidazoles, the allylamines-benzylamines and the hydroxypyridones, which are also effective against most of the moulds. Oral therapy for tinea pedis, although not well studied, should be limited to patients with more extensive infections, such as vesicobullous and moccasin type, resistant infections or chronic infections. In addition, oral agents should also be considered in diabetic and immunosuppressed patients. On the other hand, treatment of onychomycosis of the foot usually requires systemic therapy. Griseofulvin is the least effective agent when compared with the newer agents. Terbinafine, itraconazole and fluconazole have been shown to have acceptable cure rates. More recently, topical treatment of the nail with 8% ciclopirox nail lacquer, bifonazole with urea and amorolfine have been reported to be successful. Over the past decade, fungal foot infections of the skin and nail are more effectively treated with the introduction of numerous topical and oral agents.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.2165/00002512-200421020-00003" target="_blank" rel="noreferrer noopener">10.2165/00002512-200421020-00003</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2004
Administration
Antifungal Agents – Administration and Dosage
Antifungal Agents – Adverse Effects
Antifungal Agents – Pharmacokinetics
Antifungal Agents – Therapeutic Use
Clinical Trials
Diabetes Mellitus – Complications
Drug Interactions
Drugs & aging
Foot Diseases – Classification
Foot Diseases – Diagnosis
Foot Diseases – Drug Therapy
Foot Diseases – Epidemiology
Foot Diseases – Etiology
Foot Diseases – Microbiology
Foot Diseases – Symptoms
Joseph WS
Mycoses – Classification
Mycoses – Diagnosis
Mycoses – Drug Therapy
Mycoses – Epidemiology
Mycoses – Etiology
Mycoses – Microbiology
Mycoses – Symptoms
Oral
Tan J S
Topical